SCHEMBL688690

SCHEMBL688690

CCOC(=O)c1c(-c2ccsc2)csc1N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 1.00
HSD17B10 Q99714 5/20 1.00
MEN1 O00255 4/20 1.00
KMT2A Q03164 4/20 1.00
ALOX15 P16050 3/20 1.00
USP2 O75604 1/20 1.00
PRKCZ Q05513 9/20 0.71
ALDH1A1 P00352 9/20 0.70
HPGD P15428 2/20 0.70
PRKCI P41743 2/20 0.65
GAA P10253 2/20 0.64
KEAP1 Q14145 1/20 0.64
MPI P34949 1/20 0.61
MAPK1 P28482 4/20 0.60
TDP1 Q9NUW8 2/20 0.60
CASP1 P29466 1/20 0.60
CASP7 P55210 1/20 0.60
CHEK2 O96017 1/20 0.54
RECQL P46063 1/20 0.53
TSHR P16473 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL690278 0.83 PRKCZ (0.84) MAPTHSD17B10MEN1KMT2AALOX15
SCHEMBL8289654 0.83 PRKCZ (1.00) MAPTHSD17B10MEN1KMT2AALOX15
SCHEMBL1190649 0.83 PRKCZ (0.80) MAPTHSD17B10MEN1KMT2AALOX15
SCHEMBL1554182 0.82 PRKCZ (0.82) MAPTHSD17B10MEN1KMT2AALOX15
SCHEMBL689871 0.82 ALDH1A1 (1.00) MAPTHSD17B10MEN1KMT2AALOX15
SCHEMBL8290363 0.82 PRKCZ (0.82) MAPTHSD17B10MEN1KMT2AALOX15
SCHEMBL689112 0.81 PRKCZ (0.80) MAPTHSD17B10MEN1KMT2AALOX15
SCHEMBL689204 0.81 PRKCZ (1.00) MAPTHSD17B10MEN1KMT2AALOX15
SCHEMBL689452 0.81 PRKCZ (0.80) MAPTHSD17B10MEN1KMT2AALOX15
SCHEMBL690269 0.81 PRKCZ (1.00) MAPTHSD17B10MEN1KMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1953148-B1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2012-02-29 EP disclosed
US-7915267-B2 Heterocyclic amide compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-03-29 US disclosed
US-20090137603-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-05-28 US disclosed
EP-1953148-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2008-08-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137603-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF MMP2, MMP9, MMP1 MAPT 4287/4885HSD17B10 832/4885MEN1 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.